Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H. Linde

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Cancer Cell|January 27, 2023
Neutrophil-activating therapy for the treatment of cancerIan L Linde, Tyler R Prestwood, Jingtao Qiu, et al.
Journal of Virology|February 28, 2006
Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus controlRosario Zuñiga, Aldo Lucchetti, Patricia Galvan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 2016
IgG Binding Characteristics of Rhesus Macaque FcγRYing N Chan, Austin W Boesch, Nana Y Osei-Owusu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responsesFlorian Bihl, Nicole Frahm, Loriana Di Giammarino, et al.
Cancer Cell|January 9, 2024
Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapiesErica T Goddard, Miles H Linde, Shivani Srivastava, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
Increased sequence diversity coverage improves detection of HIV-specific T cell responsesNicole Frahm, Daniel E Kaufmann, Karina Yusim, et al.
Cancer Discovery|March 1, 2023
Reprogramming Cancer into Antigen-Presenting Cells as a Novel ImmunotherapyMiles H Linde, Amy C Fan, Thomas Köhnke, et al.
Journal of Virology|July 30, 2005
HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus loadNicole Frahm, Sharon Adams, Photini Kiepiela, et al.
Nature Immunology|December 22, 2005
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopesNicole Frahm, Photini Kiepiela, Sharon Adams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2019
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain TumorsRobbie G Majzner, Johanna L Theruvath, Anandani Nellan, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancer Cell|January 27, 2023
Neutrophil-activating therapy for the treatment of cancerIan L Linde, Tyler R Prestwood, Jingtao Qiu, et al.
Journal of Virology|February 28, 2006
Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus controlRosario Zuñiga, Aldo Lucchetti, Patricia Galvan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 2016
IgG Binding Characteristics of Rhesus Macaque FcγRYing N Chan, Austin W Boesch, Nana Y Osei-Owusu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responsesFlorian Bihl, Nicole Frahm, Loriana Di Giammarino, et al.
Cancer Cell|January 9, 2024
Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapiesErica T Goddard, Miles H Linde, Shivani Srivastava, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
Increased sequence diversity coverage improves detection of HIV-specific T cell responsesNicole Frahm, Daniel E Kaufmann, Karina Yusim, et al.
Cancer Discovery|March 1, 2023
Reprogramming Cancer into Antigen-Presenting Cells as a Novel ImmunotherapyMiles H Linde, Amy C Fan, Thomas Köhnke, et al.
Journal of Virology|July 30, 2005
HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus loadNicole Frahm, Sharon Adams, Photini Kiepiela, et al.
Nature Immunology|December 22, 2005
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopesNicole Frahm, Photini Kiepiela, Sharon Adams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2019
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain TumorsRobbie G Majzner, Johanna L Theruvath, Anandani Nellan, et al.
Pageof 4